Abstract:Background: In phenylketonuria (PKU) patients, the combination of two phenylalanine hydroxylase (PAH) alleles is the main determinant of residual enzyme activity in vivo and in vitro. Inconsistencies in genotype-phenotype correlations have been observed in compound heterozygous patients and a particular combination of two PAH alleles may produce a phenotype that is different from the expected one, possibly due to interallelic complementation. Methods: A dual eukaryotic vector system with two distinct PAH proteins N-terminally fused to different epitope tags was used to investigate the co-expression of PAH alleles reported in patients with inconsistent phenotypes. PAH variant proteins were transiently co-transfected in COS-7 cells. PAH activity was measured by liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS-MS), and protein expression was measured by Western blot. Genotypes were compared with predicted PAH activity from the PAH locus-specific database (PAHvdb) and with phenotypes and tetrahydrobiopterin (BH4) responsiveness from more than 10,000 PKU patients (BIOPKU database). Results: Through the expression and co-expression of 17 variant alleles we demonstrated that interallelic interaction could be both positive and negative. The co-expressions of p.[I65T];[R261Q] (19.5% activity; predicted 43.5%) and p.[I65T];[R408W] (15.0% vs. 26.8% activity) are examples of genotypes with negative interallelic interaction. The co-expressions of p.[E178G];[Q232E] (55.0% vs.36.4%) and p.[P384S];[R408W] (56.1% vs. 40.8%) are examples of positive subunit interactions. Inconsistencies of PAH residual enzyme activity in vitro and of PKU patients' phenotypes were observed as well. The PAH activity of p.[R408W];[A300S] is 18.0% of the wild-type activity; however, 88% of patients with this genotype exhibit mild hyperphenylalaninemias (MHPs). Conclusion: The co-expression of two distinct PAH variants revealed possible dominance effects (positive or negative) by one of the variants on residual PAH activity as a result of interallelic complementation.

Phenylketonuria: genotype-phenotype correlations based on expression analysis of structural and functional mutations in PAH

The Genetic Landscape and Epidemiology of Phenylketonuria.

[In Vitro Expression and Structural Analysis of Four Missense Mutations (G247S, E280G, P362T, A434D) of Phenylalanine Hydroxylase Gene].

Analysis of the Genotype-Phenotype Correlation in Patients with Phenylketonuria in Mainland China

Functional Characterization of Novel Phenylalanine Hydroxylase p.Gln226Lys Mutation Revealed Its Non-responsiveness to Tetrahydrobiopterin Treatment in Hepatoma Cellular Model

Co-expression of phenylalanine hydroxylase variants and effects of interallelic complementation on in vitro enzyme activity and genotype-phenotype correlation

Mutation Spectrum of PAH Gene in Phenylketonuria Patients in Northwest China: Identification of Twenty Novel Variants

In Vitro Residual Activities in 20 Variants of Phenylalanine Hydroxylase and Genotype-Phenotype Correlation in Phenylketonuria Patients.

[Identification of Novel Mutations in the Phenylalanine Hydroxylase Gene of Classical Phenylketonuria].

Phenylketonuria Mutations in Northern China

[Ten Novel Mutations in the Phenylalanine Hydroxylase Gene Identified in Chinese Patients with Phenylketonuria].

Unravelling the Complex Denaturant and Thermal-Induced Unfolding Equilibria of Human Phenylalanine Hydroxylase

Mutations in exon 7 of the phenylalanine hydroxylase (PAH) gene in chinese patients with phenylketonuria

Molecular Characterisation of Phenylketonuria in a Chinese Mainland Population Using Next-Generation Sequencing

Mutations in exon 6 and 7 of the phenylalanine hydroxylase(PAH) gene in chinese patients with phenylketonuria

Mutations in exon 7 of the phenylalanine hydroxylase (PAH) gene in chinese patients with phenylketonuria]

Study on Mutations of Exon 12 of the PAH Gene in 127 Phenylketonuria Patients

Phenylketonuria (PKU) Urinary Metabolomic Phenotype Is Defined by Genotype and Metabolite Imbalance: Results in 51 Early Treated Patients Using Ex Vivo 1H-NMR Analysis

Mutations of the Phenylalanine Hydroxylase Gene in Patients with Phenylketonuria in Shanxi, China.

Missense mutations prevalent in Orientals with phenylketonuria: molecular characterization and clinical implications.

Molecular diagnosis of Phenylketonuria in 157 Families and Prenatal Diagnosis of Phenylketonuria